-
Product Insights
Kelch Like ECH Associated Protein 1 – Drugs In Development, 2023
Global Markets Direct’s Kelch Like ECH Associated Protein 1 provides in depth analysis on Kelch Like ECH Associated Protein 1 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SFX-01 in Metastatic Breast Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SFX-01 in Metastatic Breast Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SFX-01 in Metastatic Breast Cancer Drug Details: SFX-01 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SFX-01 in Autism Spectrum Disorder (ASD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SFX-01 in Autism Spectrum Disorder (ASD) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SFX-01 in Autism Spectrum Disorder (ASD) Drug Details: SFX-01...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BAY-3605349 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BAY-3605349 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BAY-3605349 in Solid Tumor Drug Details: BAY-3605349 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Eptinezumab in Cluster Headache Syndrome (Cluster Headache)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Eptinezumab in Cluster Headache Syndrome (Cluster Headache) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Eptinezumab in Cluster Headache Syndrome (Cluster Headache) Drug...
-
Product Insights
Huaneng ECH – Xintai PV Power Plant 100 M – Shandong
Equip yourself with the essential tools needed to make informed and profitable decisions with our Huaneng ECH - Xintai PV Power Plant 100 M - Shandong report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive...
-
Product Insights
MET Mauritania – Nema-Amourj-Adel Bagrou Road Development – Hodh ech Chargui
Equip yourself with the essential tools needed to make informed and profitable decisions with our MET Mauritania - Nema-Amourj-Adel Bagrou Road Development - Hodh ech Chargui report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive...
-
Product Insights
Net Present Value Model: Vyepti
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Vyepti Drug Details Eptinezumab (Vyepti) is...
-
Product Insights
MET Mauritania – Nema-Anbeekat Lahoache Road Development – Hodh ech Chargui
Equip yourself with the essential tools needed to make informed and profitable decisions with our MET Mauritania - Nema-Anbeekat Lahoache Road Development - Hodh ech Chargui report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive...